hederagenin has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Yang, W | 1 |
| Deng, C; Han, RY; Jia, J; Su, HW; Tan, RZ; Wang, L; Xie, KH; Xu, LH; Zhong, X | 1 |
| Jiang, H; Ma, W; Yang, G; Yang, W; Yi, Q | 1 |
3 other study(ies) available for hederagenin and Cirrhosis
| Article | Year |
|---|---|
The protective effect of hederagenin on renal fibrosis by targeting muscarinic acetylcholine receptor.
Topics: Cell Line; Fibrosis; Humans; Kidney; Kidney Diseases; Oleanolic Acid; Pilocarpine; Receptors, Muscarinic; Transforming Growth Factor beta | 2022 |
Hederagenin ameliorates renal fibrosis in chronic kidney disease through blocking ISG15 regulated JAK/STAT signaling.
Topics: Animals; Fibrosis; Kidney; Mice; Mice, Inbred C3H; Renal Insufficiency, Chronic; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction | 2023 |
Hederagenin inhibits high glucose-induced fibrosis in human renal cells by suppression of NLRP3 inflammasome activation through reducing cathepsin B expression.
Topics: Cathepsin B; Diabetic Nephropathies; Fibrosis; Glucose; Humans; Inflammasomes; NLR Family, Pyrin Domain-Containing 3 Protein; RNA, Messenger | 2023 |